- Home
- JANX vs SBSI Comparison
JANX vs SBSI Comparison
Compare JANX & SBSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JANX | SBSI |
|---|---|---|
| Founded | 2017 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 847.1M | 974.1M |
| IPO Year | 2021 | 1995 |
Fundamental Metrics
Financial Performance| Metric | JANX | SBSI |
|---|---|---|
| Price | $14.58 | $32.80 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 3 |
| Target Price | ★ $47.00 | $35.33 |
| AVG Volume (30 Days) | ★ 877.9K | 64.3K |
| Earning Date | 05-08-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 4.42% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.78 |
| Revenue | ★ $10,000,000.00 | N/A |
| Revenue This Year | N/A | $28.87 |
| Revenue Next Year | N/A | $5.82 |
| P/E Ratio | ★ N/A | $42.19 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.12 | $26.32 |
| 52 Week High | $35.34 | $34.53 |
Technical Indicators
Market Signals| Indicator | JANX | SBSI |
|---|---|---|
| Relative Strength Index (RSI) | 52.20 | 51.17 |
| Support Level | $13.15 | $31.73 |
| Resistance Level | $15.49 | $34.06 |
| Average True Range (ATR) | 0.52 | 0.69 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 80.14 | 70.31 |
Price Performance
Historical ComparisonAbout JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
About SBSI Southside Bancshares Inc.
Southside Bancshares Inc is a bank holding company. Through its subsidiary, it operates as a financial institution offering various financial services to individuals, businesses, municipal entities, and nonprofit organizations. These services include consumer and commercial loans, deposit accounts, wealth management and trust services, brokerage services, and safe deposit services. The company's primary market areas are East Texas, Southeast Texas, and the greater Dallas-Fort Worth, Austin, and Houston, Texas.